Detailansicht

Wissensnetz

Person

Inga Zerr

Name	Inga Zerr
Zeit	1993- (Wirkungsdaten)
Ort	Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Familie	Irene Zerr (Mutter)
Weitere Angaben	Dissertation im Fachbereich Medizin an der Universität Göttingen
Datensatztyp	Person
GND-Nummer	124888585
Datensatz-ID	124888585
Beteiligt an alle anzeigen Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis The comorbidity and co-medication profile of patients with progressive supranuclear palsy The comorbidity and co-medication profile of patients with progressive supranuclear palsy SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays Die Auswirkungen der zahnärztlichen Behandlung in Intubationsnarkose auf die mundgesundheitsbezogene Lebensqualität von Patienten mit kognitiver Einschränkung Role of prion protein in synucleinopathies Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3 Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy Plasma YKL-40 in the spectrum of neurodegenerative dementia Cadmium induces GAPDH- and- MDH mediated delayed cell aging and dysfunction in Candida tropicalis 3Aer Biomarker in der Diagnostik und Differentialdiagnostik der vaskulären Demenz bei zerebraler Mikroangiopathie Entwicklung eines PrPc-Detektions-Assays zur Analyse der Fragestellung, welchen Einfluss PRNP-Mutationen oder Genpolymorphismen in CJK-Patienten auf die PrPc-Expression haben Regional-dependent, comprehensive characterization of miRNA signatures in sporadic Creutzfeldt-Jakob Disease and early Alzheimer’s Disease-type neuropathology Seeding and structural varibility in α-synucleinopathies : Seeding variability of different alpha-synuclein strains Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study cMRT-Auffälligkeiten und Symptomatik bei CJK-Patienten - Gibt es eine Korrelation zwischen cMRT-Veränderungen und der klinischen Symptomatik Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein Heart-Fatty Acid Binding Protein und α-Synuklein im Serum als mögliche Markerkandidaten für Parkinson und Demenz Liquorveränderungen bei Meningeosis neoplastica - eine retrospektive Studie (2001-2012) - YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias Molecular basis of Cd+2 stress response in Candida tropicalis MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations Vaskuläre Demenzen Der Einfluss des Apo-E4-Allels auf Liquorparameter und MRT-Veränderungen bei sporadischer Creutzfeldt-Jakob-Krankheit und deren Abhängigkeit von der Familienanamnese Identification and characterization of proteomic regulations in the cerebellum region of brain in MM1 and VV2 subtypes of sporadic Creutzfeldt-Jakob disease (sCJD) : Proteome Profiling of sCJD brain tissue Immunologisches Profil und PrPC-Expression von Patienten mit subkortikaler vaskulärer Enzephalopathie und vaskulärem kognitivem Impairment MMSE-Präprogressionsrate als potentieller Prädikator des kognitiven und funktionellen Progresses der Alzheimer-Demenz Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies Hereditary Human Prion Diseases: an Update Signalsteigerung und Korrelation mit histopathologischen Veränderungen Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer’s Disease Abschied für immer – schleichend rasant : Diagnose: Creutzfeldt-Jakob Charakterisierung von Prädiktoren rapid-progressiver Verläufe des M. Alzheimer Die Prion-Protein-Isoformen Klinische und diagnostische Eigenschaften der sporadischen Creutzfeldt-Jakob-Krankheit bei Patienten mit positiver Familienanamnese für Demenz oder Morbus Parkinson Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease Steroid-responsive Enzephalopathie bei Autoimmunthyreoiditis als Differentialdiagnose der Creutzfeldt-Jakob-Krankheit Untersuchungen zu den selbst-replizierenden Eigenschaften des pathogenen Prion-Proteins beim Menschen Clinical findings and diagnosis in genetic prion diseases in Germany Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Inga Zerr

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysis

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease

A new tetra-plex fluorimetric assay for the quantification of cerebrospinal fluid β-amyloid42, total-tau, phospho-tau and α-synuclein in the differential diagnosis of neurodegenerative dementia

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

Die Auswirkungen der zahnärztlichen Behandlung in Intubationsnarkose auf die mundgesundheitsbezogene Lebensqualität von Patienten mit kognitiver Einschränkung

Role of prion protein in synucleinopathies

Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency

The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid

Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

Plasma YKL-40 in the spectrum of neurodegenerative dementia

Cadmium induces GAPDH- and- MDH mediated delayed cell aging and dysfunction in Candida tropicalis 3Aer

Biomarker in der Diagnostik und Differentialdiagnostik der vaskulären Demenz bei zerebraler Mikroangiopathie

Entwicklung eines PrPc-Detektions-Assays zur Analyse der Fragestellung, welchen Einfluss PRNP-Mutationen oder Genpolymorphismen in CJK-Patienten auf die PrPc-Expression haben

Regional-dependent, comprehensive characterization of miRNA signatures in sporadic Creutzfeldt-Jakob Disease and early Alzheimer’s Disease-type neuropathology

Seeding and structural varibility in α-synucleinopathies : Seeding variability of different alpha-synuclein strains

Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy

Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia

Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases

Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie

Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases

Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study

cMRT-Auffälligkeiten und Symptomatik bei CJK-Patienten - Gibt es eine Korrelation zwischen cMRT-Veränderungen und der klinischen Symptomatik

Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein

Heart-Fatty Acid Binding Protein und α-Synuklein im Serum als mögliche Markerkandidaten für Parkinson und Demenz

Liquorveränderungen bei Meningeosis neoplastica - eine retrospektive Studie (2001-2012) -

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

Molecular basis of Cd+2 stress response in Candida tropicalis

MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology

Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease

Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease

Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease

Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations

Vaskuläre Demenzen

Der Einfluss des Apo-E4-Allels auf Liquorparameter und MRT-Veränderungen bei sporadischer Creutzfeldt-Jakob-Krankheit und deren Abhängigkeit von der Familienanamnese

Identification and characterization of proteomic regulations in the cerebellum region of brain in MM1 and VV2 subtypes of sporadic Creutzfeldt-Jakob disease (sCJD) : Proteome Profiling of sCJD brain tissue

Immunologisches Profil und PrPC-Expression von Patienten mit subkortikaler vaskulärer Enzephalopathie und vaskulärem kognitivem Impairment

MMSE-Präprogressionsrate als potentieller Prädikator des kognitiven und funktionellen Progresses der Alzheimer-Demenz

Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress

Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

Hereditary Human Prion Diseases: an Update

Signalsteigerung und Korrelation mit histopathologischen Veränderungen

Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study

Strain-Specific Altered Regulatory Response of Rab7a and Tau in Creutzfeldt-Jakob Disease and Alzheimer’s Disease

Abschied für immer – schleichend rasant : Diagnose: Creutzfeldt-Jakob

Charakterisierung von Prädiktoren rapid-progressiver Verläufe des M. Alzheimer

Die Prion-Protein-Isoformen

Klinische und diagnostische Eigenschaften der sporadischen Creutzfeldt-Jakob-Krankheit bei Patienten mit positiver Familienanamnese für Demenz oder Morbus Parkinson

Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease

Steroid-responsive Enzephalopathie bei Autoimmunthyreoiditis als Differentialdiagnose der Creutzfeldt-Jakob-Krankheit

Untersuchungen zu den selbst-replizierenden Eigenschaften des pathogenen Prion-Proteins beim Menschen

Clinical findings and diagnosis in genetic prion diseases in Germany

Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic

Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage

Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease